Psoriasis Completed Phase 4 Trials for Alefacept (DB00092)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00655564Long-Term One Year Use of Alefacept (AmeviveĀ®) in Moderate to Severe Chronic Plaque Type PsoriasisTreatment